Salient Surgical Technologies to Introduce TRANSCOLLATION(R) Technology to Provide Hemostasis During Kidney Surgeries
Published: Jan 24, 2011
PORTSMOUTH, N.H.--(BUSINESS WIRE)--Privately-held Salient Surgical Technologies, Inc., today announced that it will be introducing the AQUAMANTYS® bipolar sealer product line to surgeons for use in partial nephrectomy procedures. Salient's AQUAMANTYS System uses TRANSCOLLATION technology, a proprietary combination of radiofrequency energy and saline that enables surgeons to prevent and stop bleeding of soft tissue and bone during surgery and thereby decrease the risk of blood transfusions. This technology has already been used to improve patient care for more than 500,000 patients undergoing orthopaedic reconstruction, spine, brain tumor resection, trauma, and surgical oncology procedures.